Abstract

Continuous renal replacement therapy (CRRT) is a form of dialysis prescribed to severely ill patients who cannot tolerate regular hemodialysis. However, as the patients are typically very ill to begin with, there is always uncertainty whether they will survive during or after CRRT treatment. Because of outcome uncertainty, a large percentage of patients treated with CRRT do not survive, utilizing scarce resources and raising false hope in patients and their families. To address these issues, we present a machine learning-based algorithm to predict short-term survival in patients being initiated on CRRT. We use information extracted from electronic health records from patients who were placed on CRRT at multiple institutions to train a model that predicts CRRT survival outcome; on a held-out test set, the model achieves an area under the receiver operating curve of 0.848 (CI = 0.822–0.870). Feature importance, error, and subgroup analyses provide insight into bias and relevant features for model prediction. Overall, we demonstrate the potential for predictive machine learning models to assist clinicians in alleviating the uncertainty of CRRT patient survival outcomes, with opportunities for future improvement through further data collection and advanced modeling.

Despite decades of use in clinical care, only half of individuals who receive continuous renal replacement therapy (CRRT) benefit, and no consensus exists around who should be placed on CRRT. Here, the authors use electronic health record data from multiple institutions to improve prediction of CRRT response before initiating treatment

Details

Title
Data-driven prediction of continuous renal replacement therapy survival
Author
Zamanzadeh, Davina 1   VIAFID ORCID Logo  ; Feng, Jeffrey 2   VIAFID ORCID Logo  ; Petousis, Panayiotis 3   VIAFID ORCID Logo  ; Vepa, Arvind 2   VIAFID ORCID Logo  ; Sarrafzadeh, Majid 1 ; Karumanchi, S. Ananth 4   VIAFID ORCID Logo  ; Bui, Alex A. T. 2   VIAFID ORCID Logo  ; Kurtz, Ira 5   VIAFID ORCID Logo 

 University of California, Los Angeles, Department of Computer Science, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718) 
 University of California, Los Angeles, Medical & Imaging Informatics Group, Los Angeles, USA (GRID:grid.468726.9) (ISNI:0000 0004 0486 2046) 
 University of California, Los Angeles, Clinical and Translation Science Institute, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718) 
 Cedars-Sinai Medical Center, Department of Medicine, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905) 
 David Geffen School of Medicine, University of California, Los Angeles, Department of Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); David Geffen School of Medicine, University of California, Los Angeles, Brain Research Institute, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718) 
Pages
5440
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3072928723
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.